Evaluation of Antifungal Activity of Ring-Substituted Styrylquinolines Against Clinical Candida Isolates
Acta Poloniae Pharmaceutica - Drug Research · 21.05.2026 · 82 (6) · 941-952
DOI: 10.32383/appdr/218124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 21.05.2026. Verfasst von Wioleta Cieślik und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Invasive fungal infections pose a growing global health challenge, particularly in immuno-compromised patients, underscoring the need for new antifungal agents. In this study, sixteen previously synthesized ring-substituted styrylquinolines were evaluated for the first time against clinical isolates of Candida spp. Their lipophilicity was experimentally determined using RP-HPLC and compared with predicted log P values. Whereas earlier reports had as-sessed antifungal activity and lipophilicity only for a limited subset of these derivatives (compounds 8–9 and 12–16), and exclusively against reference Candida strains. The present work substantially expands this dataset by including all sixteen derivatives and introducing new activity data for clinically and reference isolates. Several derivatives exhibited notable antifungal activity, with compounds 15 and 16 showing MIC values in the submicromolar to low-micromolar range, in some cases surpassing the activity of fluconazole. Structure–activity analysis indicates that the 5,7-dichloro-8-hydroxyquinoline scaffold combined with ethoxy substitution enhances potency. Predicted ADME parameters support favorable oral bioavailability and sufficient blood–brain barrier permeability, suggesting potential utility in systemic and CNS-related fungal infections. These findings highlight compounds 15 and 16 as promising lead structures for further development of antifungal agents effective against drug-resistant clinical isolates.
Zitieren
APA
Cieślik, W., Hahn, P., Jampilek, J., & Musioł, R. (2026). Evaluation of Antifungal Activity of Ring-Substituted Styrylquinolines Against Clinical Candida Isolates. Acta Poloniae Pharmaceutica - Drug Research, 82(6), 941-952. https://doi.org/10.32383/appdr/218124
Vancouver
Cieślik W, Hahn P, Jampilek J, Musioł R. Evaluation of Antifungal Activity of Ring-Substituted Styrylquinolines Against Clinical Candida Isolates. Acta Poloniae Pharmaceutica - Drug Research. 2026;82(6):941-952. doi:10.32383/appdr/218124
BibTeX
@article{Cielik2026,
author = {Cieślik, Wioleta and Hahn, Przemysław and Jampilek, Josef and Musioł, Robert},
title = {Evaluation of Antifungal Activity of Ring-Substituted Styrylquinolines Against Clinical Candida Isolates},
journal = {Acta Poloniae Pharmaceutica - Drug Research},
year = {2026},
volume = {82},
number = {6},
pages = {941--952},
doi = {10.32383/appdr/218124}
}
EUVIMED